<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02233426</url>
  </required_header>
  <id_info>
    <org_study_id>NKU-001</org_study_id>
    <nct_id>NCT02233426</nct_id>
  </id_info>
  <brief_title>Effect of Hypertonic Solutions on Allergic Rhinitis Patients</brief_title>
  <acronym>hypertonic</acronym>
  <official_title>Do Hypertonic Solutions Have an Impact on Nasal Eosinophilia in Allergic Rhinitis Patients?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Namik Kemal University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Namik Kemal University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the effectivity of using hypertonic nasal solutions
      alone on the symptom scores and nasal eosinophil levels of allergic rhinitis patients,
      retrospectively.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The medical records of the patients who admitted to outpatient clinic of otorhinolaryngology
      department of a tertiary referral center were retrospectively investigated. The symptom
      scores and nasal eosinophil levels of the patients were recorded. Patients using hypertonic
      solutions alone or steroid nasal spray alone were compared.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">October 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The number of eosinophils in nasal secretions</measure>
    <time_frame>The number of eosinophils in nasal secretions that was counted before the therapy and after the first month of therapy would be recorded</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sinonasal Outcome Test (SNOT-22) questionairre scores</measure>
    <time_frame>SNOT-22 scores obtained before the treatment and after the first month of treatment would be recorded</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Allergic Rhinitis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Medical records of patients who admitted to the outpatient clinic of a tertiary referral
        center was enrolled.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with positive Prick's test to at least one allergen and diagnosed as having
             allergic rhinitis were included

          -  Patients who used hypertonic nasal solution alone for at least one month were included
             as sthe study group

          -  Patients who used nasal steroid spray alone or at least one month were included as
             sthe study group

        Exclusion Criteria:

          -  Patients with a history of asthma, urticeria, eczama, diabetes mellitus, hypertension,
             COPD and other systemic diseases were excluded
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zafer Ciftci, Assist. Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Namik Kemal University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zafer Ciftci, Assist. Prof</last_name>
    <phone>00905325540605</phone>
    <email>zaferciftci@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Namik Kemal University, Department of Otorhinolaryngology</name>
      <address>
        <city>Tekirdag</city>
        <zip>59100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zafer Ciftci, Assist. Prof</last_name>
    </contact>
    <investigator>
      <last_name>Zafer Ciftci, Assist. Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 29, 2014</study_first_submitted>
  <study_first_submitted_qc>September 3, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2014</study_first_posted>
  <last_update_submitted>September 3, 2014</last_update_submitted>
  <last_update_submitted_qc>September 3, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 8, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Namik Kemal University</investigator_affiliation>
    <investigator_full_name>Zafer Ciftci</investigator_full_name>
    <investigator_title>Assist. Prof., M.D.</investigator_title>
  </responsible_party>
  <keyword>allergic rhinitis</keyword>
  <keyword>nasal steroid</keyword>
  <keyword>hypertonic saline</keyword>
  <keyword>eosinophil</keyword>
  <keyword>symptom score</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rhinitis</mesh_term>
    <mesh_term>Rhinitis, Allergic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

